Spain to begin trials of swine flu vaccine on children

9th September 2009, Comments 0 comments

The clinical trial of a swine flu vaccine will involve 400 children aged between six months and 17 years, says the Spanish health ministry.

Madrid – Spain is to begin clinical trials of a swine flu vaccine developed by British pharmaceutical giant GlaxoSmithKline, the government said Tuesday.

The trial will involve 400 children between six months and 17 years, Health Minister Trinidad Jimenez said.

The results will be not be available for at least six months, but this would not prevent the vaccine from being used before then, she said.

GSK is among a select few leading pharmaceutical companies that are creating vaccines against the A(H1N1) virus for millions of people to take ahead of the northern hemisphere winter so that they avoid contracting the illness.

In August, the pharmaceutical announced it had launched clinical trials of its vaccine that would involve 9,000 people in Europe, Canada and the United States.

The Spanish government plans to have enough stock of swine flu vaccine to vaccinate 60 percent of the population.

A total of 25 people have died of the A(H1N1) virus in Spain, the first European country to confirm a case of the virus and the second-most affected country on the continent after Britain.

AFP / Expatica

0 Comments To This Article